Target intelligence / Profile preview

Proteasome 26S subunit, non-ATPase, 10 pseudogene 3 (PSMD10P3)

Target
PSMD10P3
Molecular classification
Pseudogene
01

Overview

Proteasome 26S subunit, non-ATPase, 10 pseudogene 3 (PSMD10P3) is a human pseudogene and does not encode a protein product. It is annotated as a nonfunctional copy of the PSMD10 gene, which encodes a subunit of the 19S regulatory particle of the 26S proteasome complex involved in ubiquitin-dependent protein degradation. Pseudogenes like PSMD10P3 typically do not have a known biological function and are not considered therapeutic targets or involved in disease mechanisms[3][5][7][11]. Context and Interpretation: PSMD10P3 is clearly annotated as a pseudogene in all major gene resources[3][5][7][11]. Unlike active genes or true protein-coding targets, pseudogenes generally do not produce functional protein products and are not implicated directly in biological processes or diseases in the way enzymatic or receptor drug targets are. There is no strong evidence for any therapeutic targeting, disease association, or drug interaction with this feature in the genome. If you are seeking information on a therapeutically relevant proteasome target, refer to actual protein-coding subunits of the 26S proteasome complex, such as PSMD10 (proteasome 26S subunit, non-ATPase 10), not the pseudogene PSMD10P3[4][10][12]. Summary of Issue: This entry refers to a pseudogene, not a functional target protein or receptor, and as such, it is not a therapeutic target and is flagged as an incorrect entry for most pharma, biology, or drug discovery applications.

Other names
Proteasome 26S non-ATPase subunit 10 pseudogenePSMD10P3

Beyond the preview

Go deeper on Proteasome 26S subunit, non-ATPase, 10 pseudogene 3 (PSMD10P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome 26S subunit, non-ATPase, 10 pseudogene 3 (PSMD10P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call